Heart Test Laboratories
HSCS
6 hedge funds and large institutions have $61.9K invested in Heart Test Laboratories in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
16% more capital invested
Capital invested by funds: $53.4K → $61.9K (+$8.51K)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.12% less ownership
Funds ownership: 1.55% → 1.43% (-0.12%)
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$37.2K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.76K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$11 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$20.9K |
| 2 |
Morgan Stanley
New York
|
-$11.9K |
| 3 |
CC
Cultivar Capital
Denton,
Texas
|
-$2.6K |
| 4 |
OLVIG
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
|
-$658 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
1
HRT Financial
New York
| $48K | +$37.2K | +10,166 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $9.1K | +$4.76K | +1,301 | +226% |
|
|
3
UBS Group
Zurich,
Switzerland
| $3.3K | -$20.9K | -5,715 | -89% |
|
|
OLVIG
4
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
| $1.48K | -$658 | -180 | -37% |
|
|
5
Bank of America
Charlotte,
North Carolina
| $34 | +$11 | +3 | +75% |
|
6
JP Morgan Chase
New York
| $5 | – | – | – |
|
|
7
Morgan Stanley
New York
| – | -$11.9K | -2,290 | Closed |
|
|
CC
8
Cultivar Capital
Denton,
Texas
| – | -$2.6K | -500 | Closed |
|
HSCS Hedge Fund Activity: Q3 2024 in Review
6 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q3 2024, worth a combined $61.9K — up 16% from $53.4K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of HSCS and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $37.2K. The largest seller was UBS Group, cutting an estimated $20.9K.
- 6 institutional investors held Heart Test Laboratories (HSCS) as of Q3 2024, down from 7 in Q2 2024.
- Funds reported $61.9K of Heart Test Laboratories stock for Q3 2024, up 16% quarter-over-quarter.
- 1 fund opened new Heart Test Laboratories positions in Q3 2024 and 2 closed out, a net change of -1 holder.
- The largest Heart Test Laboratories buyer in Q3 2024 was HRT Financial, an estimated $37.2K added.
- The largest Heart Test Laboratories seller in Q3 2024 was UBS Group, an estimated $20.9K sold.
Based on aggregated 13F filings for Q3 2024.